Sectors
FLNA
Filana Therapeutics, Inc.
0.70
10 x 1.13
10 x 1.07
bid
ask
-
0.06
7.53%
10 @ 04:01 PM
0.70 +0.00 (0.00%)
| Ytd | -64.47% | |
| 1y | -84.44% |
0.70
day range
0.76
0.68
52 week range
4.52
| Open | 0.74 | Prev Close | 0.76 | Low | 0.70 | High | 0.76 | Mkt Cap | 33.98M |
| Vol | 327.94K | Avg Vol | 2.02M | EPS | -0.86 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.65 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 0.86 | 200-d Avg | 1.44 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 9.39M | ||
| Research and Development Expense | 3.30M | ||
| Selling, General and Administrative Expense | 6.09M | ||
| Operating Income | -9.39M | ||
| Net Income | -8.60M | ||
| Net Income Common Stock | -8.60M | ||
| Net Income Common Stock (USD) | -8.60M | ||
| Consolidated Income | -8.60M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -8.60M | ||
| Earning Before Interest & Taxes (USD) | -8.60M | ||
| Weighted Average Shares | 48.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 82.68M | ||
| Cash and Equivalents (USD) | 82.68M | ||
| Current Assets | 83.72M | ||
| Property, Plant & Equipment Net | 20.18M | ||
| Total Assets | 103.90M | ||
| Current Liabilities | 40.16M | ||
| Total Liabilities | 40.29M | ||
| Accumulated Retained Earnings (Deficit) | -515.02M | ||
| Shareholders Equity | 63.61M | ||
| Shareholders Equity (USD) | 63.61M | ||
| Assets Non-Current | 20.18M | ||
| Liabilities Non-Current | 136.00K | ||
| Trade and Non-Trade Payables | 39.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 244.00K | ||
| Net Cash Flow from Financing | -16.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.89M | ||
| Net Cash Flow from Operations | -3.85M | ||
| Share Based Compensation | 4.07M | ||